Virtus ETF Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,575
| Closed | -$424K | – | 501 |
|
|
2022
Q1 | $424K | Hold |
3,575
| – | – | 0.19% | 148 |
|
|
2021
Q4 | $493K | Sell |
3,575
-983
| -22% | -$136K | 0.19% | 117 |
|
|
2021
Q3 | $633K | Sell |
4,558
-415
| -8% | -$57.6K | 0.28% | 111 |
|
|
2021
Q2 | $483K | Sell |
4,973
-2,220
| -31% | -$216K | 0.2% | 160 |
|
|
2021
Q1 | $492K | Buy |
7,193
+196
| +3% | +$13.4K | 0.21% | 150 |
|
|
2020
Q4 | $600K | Buy |
6,997
+2,326
| +50% | +$199K | 0.25% | 114 |
|
|
2020
Q3 | $304K | Sell |
4,671
-647
| -12% | -$42.1K | 0.16% | 221 |
|
|
2020
Q2 | $389K | Sell |
5,318
-1,539
| -22% | -$113K | 0.18% | 211 |
|
|
2020
Q1 | $233K | Sell |
6,857
-1,003
| -13% | -$34.1K | 0.1% | 263 |
|
|
2019
Q4 | $428K | Buy |
7,860
+3,834
| +95% | +$209K | 0.07% | 236 |
|
|
2019
Q3 | $168K | Sell |
4,026
-223
| -5% | -$9.31K | 0.03% | 272 |
|
|
2019
Q2 | $186K | Sell |
4,249
-3,160
| -43% | -$138K | 0.04% | 285 |
|
|
2019
Q1 | $381K | Sell |
7,409
-911
| -11% | -$46.8K | 0.81% | 38 |
|
|
2018
Q4 | $308K | Sell |
8,320
-3,305
| -28% | -$122K | 0.05% | 106 |
|
|
2018
Q3 | $437K | Sell |
11,625
-8,529
| -42% | -$321K | 0.05% | 145 |
|
|
2018
Q2 | $796K | Buy |
+20,154
| New | +$796K | 0.7% | 31 |
|